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ABSTRACT
Pain is the leading cause of Emergency Department (ED) visits making it one of the
primary concerns of the emergency medical field. The experience of pain is subjective and
unique to every individual making it difficult to effectively manage. As a result, the subjective
nature of pain is also commonly associated with drug-seekers often claiming to have pain simply
to receive narcotics to support their addiction. There have been numerous studies completed to
determine how to effectively recognize drug-seeking. This integrative literature review will
identify the common behaviors that have been seen as indicators of drug-seeking in the ED. The
evidence collected from articles published between 2001 and 2011 examined the use of
assessment tools, drug screening, and prescription monitoring programs for distinguishing drugseekers. The evidence did not identify a specific evaluation tool used to recognize drug-seekers;
however, the research did suggested that using these techniques can help to identify drug-seeking
behavior allowing emergency medical staff to effectively manage pain in the ED.
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INTRODUCTION
The most commonly reported symptom upon arrival in Emergency Departments (ED) is
pain, accounting for approximately 78% of all ED visits (Todd, Ducharme, Choiniere, Crandall,
& Fosnocht, 2007). Pain associated with an injury accounts for less than one-third of ED visits.
Clients most commonly complain of pain in the back, neck, abdomin, head, chest, or from an
unidentifiable source (Todd et al., 2007). Pain is initially classified as acute or chronic. Acute
pain occurs suddenly, often as the result of injury or illness; whereas, chronic pain persists over a
longer period of time. It has been estimated that one in three Americans will eventually suffer
from chronic pain due to illness or injury (Thomas, 2007). Over 50 million Americans across the
country report chronic back pain, migraine headaches, or arthritis pain on a regular basis making
pain a major medical problem (Thomas, 2007).
One of the common goals in the ED is to effectively manage pain symptoms in order to
alleviate the discomfort experienced by clients (Todd, et al., 2007). Since the implementation of
the Emergency Medical Treatment and Active Labor Act (EMTALA), EDs have been required
by law to provide care if any emergency medical condition (EMC) is present including severe
pain with an unknown source. Severe pain is considered an EMC and must be effectively
managed in the ED to alleviate symptoms. Regulations set forth by The Joint Commission on
Accreditation of Healthcare Organization (JCAHO) state that the hospital is responsible for
managing pain symptoms, and if the hospital is no longer able to meet the needs of the client, the
client must receive a referral to a pain management specialist (Dorsey, Malone, & Simopoulos,
2009).
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Problem
Pain is often a symptom of an illness or disease that cannot be directly observed by health
care providers, therefore possibly leading to a less sympathetic environment (Wilsey, Fishman,
Ogden, Tsodikov, & Bertakis, 2008b). Clinical manifestations of pain present uniquely in every
individual depending on a variety of factors including culture, age, gender, and socioeconomic
status. Clients frequently complain of pain symptoms in areas where objectively assessing an
etiology is difficult, such as headache, back and neck pain, or abdominal pain (Todd, et al.,
2007).
If pain is a result of an unidentifiable source, health care providers manage pain
symptoms with little objective data making it difficult for some health care providers to remain
compassionate for clients leading to inadequate pain management. Unsatisfactory pain
management occurs for a variety of reasons including knowledge deficit regarding chronic pain
management and ethical dilemmas (Pines & Hollander, 2008). Unfortunately, a common reason
for inadequate pain management is an unwillingness to believe the client’s report of pain (Silka,
Roth, Moreno, Merrill, & Geiderman, 2004). Improper pain management causes unnecessary
suffering and results in more than $100 billion in preventable medical expenses from longer
hospital stays, re-hospitalizations, and recurrent ED visits (Dorsey, Malone, & Simopoulos,
2009). One of the most prevalent challenges in providing effective pain management in the ED is
the inability to differentiate drug-seekers from legitimate clients experiencing pain (Hansen,
2005). A contributing factor to this problem is that screening tools to distinguish drug-seekers
from clients in pain are not widely used (Dorsey, Malone, & Simopoulos, 2009). This failure to
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separate drug-seekers from clients with legitimate pain means clients in pain may be mistaken
for drug-seekers while drug-seekers may be prescribed narcotics.
A recent article published in the Emergency Department Legal Letter (2009) states that
for every 75,000 clients seen in an ED every year 5,764 of them are drug-seekers. This implies
that approximately one in every 13 clients seen in the ED is a drug abuser seeking prescription
pain medication (Dorsey, Malone, & Simopoulos, 2009). As a result of widespread narcotic
abuse, medical professionals have developed a defensive approach in order to comply with
regulations and avoid law suits. Medical professionals with a defensive approach to pain
management will medicate all clients suffering from pain which may include drug-seekers
(Baehren, Marco, Droz, Sinha, & Callan, 2010).
Narcotics are commonly used to treat severe pain from both chronic and acute sources
and may elicit a euphoric sensation while controlling pain effectively (Wilsey, et al., 2008b). As
a result of the rapid-onset of narcotics in the central nervous system, they are also associated
with a high incidence of addictive properties after prolonged use (Hansen, 2005). Narcotics are
extremely effective for minimizing severe pain; however, due to the highly addictive properties,
medical providers are often reluctant to use them consistently. When narcotics are used to
suppress the symptoms of pain, addiction occurs in a small fraction of clients. These clients may
then seek out narcotics even when there is no longer a physical need for pain relief (Braden,
Russo, Fan, Edlund, Martin, & DeVries, 2010). Clients will often mimic or feign signs and
symptoms associated with their previous condition in an attempt to receive narcotics to support
their addiction (Chan & Winegard, 2007). The lack of adequate evidenced-based screening tools
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to identify drug-seeking behavior, in combination with drug-seeking in EDs, has been directly
associated with ineffective emergency pain management (Wilsey, et al., 2008b).
Purpose
The purpose of this integrative literature review is to identify common drug-seeking
behaviors exhibited by clients in EDs, in an attempt to minimize health care provider
uncertainties when managing pain symptoms in clients presenting to the ED complaining of
acute and/or chronic pain.
Method
An extensive literature review was completed to identify current assessment tools that are
being used to identify drug-seeking behaviors, as well as what drug seeking behaviors have
already been established. The current research available was retrieved from the following
databases: Cochrane Database of Systematic Reviews, Cumulative Index to Nursing and Allied
Literature (CINAHL), PubMed, and PsycINFO. Studies were limited to peer-reviewed research
published in English between January, 2001 and June, 2011. The comprehensive literature search
was narrowed using keywords including: drug seekers, emergency department, emergency room,
pain, pain control, pain management, prescription monitoring and substance abusers.
In order to be included in this review, articles had to meet the following criteria:
participants were 18 years and older admitted to the emergency department complaining of pain;
reporting identifiable behaviors exhibited by drug-seekers; address misconceptions associated
with non-cancer chronic pain; or be directly related to the key terms used to complete the search.
Furthermore, articles examining the use of pain scales in the ED as well as articles that contained
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research about the use of drug-seeking evaluations were reviewed. Articles were excluded if pain
was secondary to a disease process or used animals as their experimental sample.
Several studies were included to provide a basic knowledge of drug-seeking behaviors
most commonly seen in the ED. Multiple studies were used to provide background and
introductory information to establish the defining characteristics of drug-seekers, substance
abusers, and common behaviors associated with drug-seeking in the ED. For this integrative
review of research, twelve total studies met all criteria to identify common drug-seeking
behaviors associated with substance abuse. Of those studies, ten were quasi-experimental and
used convenience sampling; whereas the additional two studies were experimental and used
randomized sampling.
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Table 1: Literature Search Strategy

Database
Cochrane

EBSCO
CINAHL

PubMed

PsycINFO

Date
of Search
11/03/2010

Search
Number of
Strategy
Articles Found
“Pain Management”
116
or “Pain Control” and
“Drug Seek*” or “Drug
Abuse*”

11/01/10

“Emergency
Department” and
“Pain”

288

11

“Emergency Room”
and “Pain”

28

4

“Pain” and
“Drug Seek*”

30

2

11/03/10

“Emergency
Department
and “Pain” and
“Drug Seek*”

42

5

11/01/10

“Pain”
and “Drug Seek*”

110

6

“Emergency
Department” and
Pain Management”
Or “Pain Control”
And “Drug Seek*”

288

13

11/06/10

“Emergency
Department” and
“Substance Abuse*”
Or “Drug Seek*”

307

5

01/05/11

“Prescription Monitor*”
and “Substance Abuse*”
or “Drug Seek*”

304

3

11/07/10

“Pain Management”
or “Pain Control”

18

3

6

Number of Searched
Relevant Articles
1

BACKGROUND
Prescription opioid abuse is the intentional misuse of prescription opioids in a manner
that is not consistent with the way in which the prescribed medication was intended to be used.
Prescription medication is becoming a more commonly abused substance which has lead to an
increase in the number of ED visits related to nonmedical use of opioids (White, Birnbaum,
Schiller, Tang, & Katz, 2009). As a result of the increase in prescription substance abuse, it is
necessary to identify clients that are drug-seeking. The most common drug-seeking behaviors
have been associated with complaining of pain that is not validated by diagnostic evidence,
indicating a medication of preference or stating allergies to specific medication(s), visiting
multiple EDs, and having a mental health cormobidity in conjunction with prescription abuse
(Schuckman, Hazelett, Powell, & Steer, 2008; Wilsey, Fishman, Ogden, Tsodikov, & Bertakis,
2008a; Wilsey et al.,2008b). In addition to identifying common behaviors, it is also important for
ED care providers to recognize that stereotyping of drug-seekers in the ED minimizes effective
pain management (Kelleher & Cotter, 2009).
Pain Source
Drug-seekers will often complain of back pain, neck pain, dental pain, or migraine
headaches because these sources of pain are difficult to validate with diagnostic procedures
commonly used in the ED. Due to high client ratios in the ED it has been shown to be more
efficient to refer clients to their primary care provider for diagnostic procedures such as
computerized axial tomography scans (CT scan), magnetic resonance imaging (MRI), and x-ray
images unless there is a traumatic event or acute onset of back pain, neck pain, dental pain, or
migraine headaches (Thomas, 2007). With the chance of practitioners having difficulty in
7

definitively identifying the source of pain related to these complaints, drug-seekers have learned
that reporting these forms of pain in the ED warrant treatment with strong pain reliving
medications. In many cases clients with chronic back pain, neck pain, or migraine headaches will
not have diagnostic evidence to support their pain symptoms which is why drug-seekers often
mimic these conditions to receive strong narcotics in the ED (White, et al., 2009).
The objective signs and symptoms of chronic pain include, but are not limited to:
agitation, facial grimacing, elevated blood pressure, guarding, and restlessness. However, clients
with true chronic pain can adapt to pain over time and may show very minimal objective signs of
pain making identifying drug-seekers from clients with chronic pain even more difficult
(Hawkins, Smeeks, & Hamel, 2008).
Medication Selecting
A common behavior associated with drug-seeking is when clients will identify a
medication of choice or state that they have allergy to a specific medication which leaves the
physician with no other alternative but to prescribe a specific class of medication (Schuckman,
Hazelett, Powell, & Steer, 2008). When a client states they have an allergy to a medication, that
medication must at all cost be avoided to prevent a dangerous allergic reaction. As such, drugseekers use this to their advantage to obtain their drug of choice. The most commonly reported
allergies associated with drug-seekers include: morphine, codeine, and non-steroidal antiinflammatory drugs (NSAIDs). Whereas, the most common substances requested by clients
suspected of drug-seeking consist of narcotics and benzodiazepines (McNabb, Foot, Ting,
Breeze, & Stickley, 2006).
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Hospital Shopping
Drug-seekers will often abuse the system by hospital shopping. The term “hospital
shopping” is used to describe the method that drug-seekers use to obtain medications from
several sources by going to multiple medical facilities within their surrounding area (Schuckman,
et al., 2008). As a way to limit the likelihood of being categorized as a drug abuser, individuals
will visit multiple hospitals to obtain narcotics and decrease the number of visits on record at
each facility. Visiting multiple facilities is done in an effort to make it appear as though they visit
the ED on rare occasions, when in reality they are frequently seen in an ED. This is a technique
that mimics clients suffering from break through pain. Break through pain is a sudden increase in
chronic pain that cannot be treated with a normal pain management regimen. Chronic pain
clients will often seek care at the hospital in their area which they choose based on comfort,
familiarity, and personal standards of care. Drug-seekers will use this knowledge to their
advantage to make it appear as though they are a chronic pain client with break through pain
(Baehren et al., 2009).
Mental Heath
Several research studies show that psychiatric illnesses are commonly seen in drugseekers. Over 50% of the mentally ill suffer from a history of substance abuse including the use
of prescription medications (Wilsey, et al., 2008b). It is unclear what the ratio of drug-seekers
with a mental illness is; however, recent studies have shown that there is a high prevalence in
drug-seekers with mental health cormobidities. In a study conducted by Barth Wilsey and his
associates, 113 participants underwent an extensive interview which showed that participants
suffering from anxiety, depression, personality disorders, and post traumatic stress disorder had a
9

greater propensity for abusing prescription medications. The research shows that clients with a
history of mental illness should be evaluated for drug-seeking and vice versa (Wilsey, et al.,
2008b).
Stereotyping
One barrier to properly identifying substance abuse in the ED is practitioner stereotyping
of clients as drug-seekers (Kelleher & Cotter, 2009). It is possible for ED staff to become
impartial to clients whom they suspect of drug-seeking. Most ED care providers also recognize
commonalities in clients whom they suspect of drug-seeking which has lead to biases not as a
negative correlation but as a result of experience (Kelleher & Cotter, 2009). It is important for
the ED staff to recognize profiling as an issue and how it can hinder the care provided.
ED staff work in a state of constant stress and client lives are frequently at risk. Clients
presenting with pain complaints without objective assessment etiology are at risk for being
stereotyped as a drug-seeker. When this occurs, it may lead to improper care with up to 8% of
clients suffering from true pain being categorized as drug-seekers (Dorsey, Malone, &
Simopoulos, 2009). It is important that ED providers recognize the possibility of stereotyping
and treat clients properly.
Summary
The research shows evidence that there are identifiable drug-seeking behaviors in the ED
(Dorsey, Malone, & Simopoulos, 2009). Taking into consideration the negative impact that drugseeking has on the medical field, such as: drug-seekers take advantage of the medical system, use
vital resources, and make treatment for clients with chronic pain more difficult, it is important to
identify drug-seekers and provide the appropriate treatment to decrease the effects that drug10

seekers have on the emergency medical field. The research indicates that behaviors associated
with drug-seeking are common in the majority of drug-seekers which shows that there are
definitive ways to identify this problem and reduce prescription drug abuse in the ED (Butler et
al., 2007). It is common practice to provide the opportunity for pain medication for all clients
complaining of pain even when there is no diagnostic evidence to support their complaint. This is
because it is difficult to make an absolute conclusion when drug-seeking is suspected and if a
client presents with pain symptoms it is challenging to deny pain medication. The results from
the research show that there is evidence that specific behaviors associated with drug-seeking can
be objectively identified (White, et al., 2009).
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FINDINGS
Drug-seeking is not a recent phenomenon but is an ever present obstacle seen in EDs
throughout the world. Prescription drugs have become the second most common abused drug in
the United States which as lead to an influx in drug-seekers in the ED (Wilsey, Fishman, Ogden,
Tsodikov, & Bertakis, 2008a). There has not yet been enough research to identify an evidencebased and effective solution for managing drug-seekers in the ED. However, the included
research shows a variety of ways to identify drug-seekers. In an effort to reduce future
prescription drug abuse, research to identify drug-seeking behavior is vital. In this integrative
literature review twelve research articles were analyzed to identify the most common drugseeking behaviors and the potential methods for managing drug-seekers. The included articles
reported the following approaches to help identify drug-seekers: proper assessment, drug
screening, and prescription monitoring systems.
Assessment
Eight articles indicated that drug-seeking behavior can frequently be identified through
the use of proper assessment tools and standardized client assessment. The assessment tools
utilized demographic information with various scales and surveys constructed specifically to
identify drug abusers. The combination of; exceptional assessment skills, evidenced based
evaluation tools, common behaviors, signs and symptoms of substance abuse and objective
information can help identify drug-seekers and offer an opportunity to provide appropriate care.
An Australian study showed a correlation between drug-seeking and identifying a drug of
choice or reporting an allergy to pain medications by using a convenience sample of 37
participants. A questionnaire was developed that focused on nine subcategories including: client
12

demographics, triage category, chief complaint, psychiatric disorder, request for prescription,
past medical history and record of visits, any previously suspected drug-seeking, allergies to
medications, medications sought by clients, medication administered in the ED, diagnostic
procedures implemented, and disposition details (Schuckman, et al., 2008).
The questionnaire was filled out by the physician when he or she suspected a client of
drug-seeking. The results showed 11% of the participants reported an allergy to morphine,
codeine, and non-steroidal anti-inflammatory drugs (NSAIDs). Furthermore, nearly 90% of the
clients suspected of drug-seeking indicated a drug of choice. Out of the 37 clients suspected of
drug-seeking, 81% requested a narcotic drug and 8% requested a benzodiazepine. Over half of
the clients (62%) reported a primary complaint of abdominal, back, chest, head, or neck pain.
Over one-third (38%) of the subjects had been seen multiple times in the ED; whereas, only 2%
of the subjects were diagnosed with a new organic disorder (McNabb, et al., 2006).
The data obtained from this study supported the theory that drug-seekers are likely to
report a drug of choice and/or state allergies to medication in order to obtain a drug of choice,
and visit several EDs on multiple occasions in order to support their addiction. This research also
shows that ED staff has a tendency to categorize psychiatric clients as drug-seekers and
psychiatric screenings should be completed when drug-seeking is suspected. Overall, the
findings in this study clearly provided the information that the researchers indented to find. The
aim of this study was to identify commonalities among clinical presentations where physicians
suspect drug-seeking behaviors (McNabb, et al., 2006).
This study was limited by a small sample size and the use of only one facility located in a
large metropolitan area. In order for this research to be utilized in a developing a way to screen
13

clients suspected of drug-seeking in the ED a larger study will need to be conducted in multiply
ED locations and participants should be obtained through randomized sampling. This
preliminary study provides a base for developing a larger scale experiment that will help to
define the characteristics of a tool that can be utilized in the ED to screen clients suspected of
drug-seeking (McNabb, et al., 2006).
In a much larger study, de-identified medical records of 632,000 privately insured
residents were analyzed for commonalities among substance abusers. A client was considered a
substance abuser based on the number of opioid prescriptions issued within one year (White, et
al., 2009). The results indicated that those suspected of prescription opioid abuse were
predominately male between 25 and 34 years of age. Behavioral characteristics associated with
abuse were filling prescriptions at two or more pharmacies, having one or more early refills, and
demonstrating two or more consecutive months of dose escalation. This study shows the
feasibility in developing an algorithm that can be utilized to identify common behaviors and
biographical information among drug abusers in order to incorporate that information into
developing a screening tool to identify drug-seekers in the ED (White, et al., 2009). It also shows
how insurance companies may be able to partner with ED providers to help identify and prevent
prescription opioid abuse.
A study was completed to develop a tool to identify substance abusers called the Current
Opioid Misuse Measurement (COMM, 2009) scale. The COMM was developed by a team of 26
pain management specialists, addiction experts, and primary care providers dedicated to
constructing a clinical tool that could be used to screen the chronic pain population for
prescription drug abuse. The COMM is a 42 question assessment tool comprised of statements
14

that were developed through intergrading six subcategories, including: signs and symptoms of
misuse, emotional problems or psychiatric issues, poor response to medication, evidence of lying
and drug use, medication misuse and noncompliance, and appointment patterns. The COMM
focused on uncovering the truth by administering a subjective questionnaire with statements to
be rated on a scale of 0-4 by the suspected prescription abuser (Butler, et al., 2007).
The first trial of 200 subjects participated in a week long study in which the results of the
COMM were compared to the results of a urinalysis. Initial results showed the instrument was
helpful in identifying chronic pain clients with a prescription misuse problem. Further analysis
identified 40 items as being relevant and 17 as being more likely to identify a client currently
abusing prescription medications. Although the COMM may be useful in the ED setting,
researchers constructed this tool to be used for the chronic pain population with a current pain
management regimen (Butler, et al., 2007).
A later analysis of the COMM was completed by a group of researchers working to
establish an assessment tool that would help to identify prescription drug abusers not currently
under supervision of a primary care physician. A team of seven researchers affiliated with the
Clinical Addiction Research and Education (CARE) Unit of Boston Medical Center and Boston
University School of Medicine approached 2,194 clients in the safety-net hospitals. The
participants observed in this study had to meet the following inclusion criteria: 18–60 years of
age, English speaking, have suffered from chronic pain for at least the past three months,
reported use of analgesic medication within the past month, and had at least one prescription for
an opioid in the year prior to the study. Out of the 2,194 clients interviewed only 238 met the
inclusion criteria and agreed to participate in the study (Meltzer et al., 2010).
15

Their goal was to identify participants suffering from a substance abuse disorder by
administering a shorter version of the COMM using the 17 questions determined to be more
effective. During the interview portion of the study, each participant was administered the
COMM in which the following key variables were examined: sociodemographic factors, income,
level of education, marital status, health insurance, presence of a major depressive disorder,
family history of substance abuse disorder (SUD), and current use of tobacco products. The
results indicated that 11% of the participants currently had prescription drug abuse disorder
(PDD) and 7% of the participants currently had substance use disorder (SUD). Although the
remaining 8% had no disorder, 24% of these participants previously had PDD or SUD (Meltzer,
et al., 2010).
In order to support the reliability of the COMM the results were subjected to a parametric
analysis of variance (ANOVA) and nonparametric analyses (Kruskal–Wallis) which indicated
the same significant results. Participants with PDD were more likely to be female, AfricanAmerican, have a lower level of education, have some form of major depressive disorder, use
tobacco products, have alcohol dependence, and be on some form of disability (Meltzer, et al.,
2010).
Results of this study support that clients with PDD and/or SUD can be identified using a
shorter assessment tool. The shorter COMM (17 questions) may be more appropriate for use in
settings with great time constraints such as the ED. The instrument, however, was only evaluated
in a primary care setting. Although participants were approached in a hospital setting they were
later interviewed in a primary care setting by physicians, master’s degree-level professionals,
college graduates, and college students who underwent over 60 hours of interview training
16

(Meltzer, et al., 2010). In order to make this research more applicable for emergency care
professionals, additional research would need to be conducted solely in an ED setting.
A separate randomized trial reported similar results by interviewing clients with chronic
back and neck pain (Jamison et al., 2010). This study was conducted in an effort to identify
potential for opioid misuse by six researchers affiliated with the Pain Management Center and
Harvard Medical School. The sample consisted of participants that met the following inclusion
criteria: suffering from chronic back or neck pain, currently using prescribed long-acting opioids
for pain for more than six months, show no signs of medication misuse, have an average score of
4 or greater on the 0-10 pain scale, English speaking, and have a risk for substance abuse
indicated by a score of six or higher on the Screener for Opioid Abuse for Pain Patients
(SOAPP). A total of 62 participants were recruited to take part in a six month trial and received a
comprehensive physical and history exam by a physician prior to the study. The physician
reviewed their pain management therapy which all participants were required to adhere to
throughout the study. Participants were subdivided into three randomized groups based on their
SOAPP score. The three groups were placed into a high-risk control group, a high-risk
experimental group, or a low-risk experimental group.
The high risk and low risk experimental groups each had to complete a monthly
electronic diary; whereas, the high risk control group was required to complete a monthly
electronic diary, urinalysis, and attend compliance counseling. Each group was required to
complete a pre-treatment and post treatment assessment including completing the following
questionnaires: The Brief Pain Inventory (BPI), The Hospital Anxiety and Depression Scale
(HADS), and The Pain Disability Index (PDI). Surprisingly the HADS assessment showed
17

similar scores for all three groups indicating that anxiety and depression do not significantly
affect the risk for substance abuse. However, the BPI and the PDI assessments showed a
significant difference among the three groups, which was a correlation between a greater severity
of debilitating pain and an increased risk of developing substance misuse. The high-risk control
group was 50% more likely to abuse substances than the high-risk and low-risk experimental
groups (Jamison, et al., 2010).
The Prescription Drug Use Questionnaire (PDUQ) is among the most well-developed
substance abuse evaluation method for pain clients at this time (Jamison, et al., 2010; Meltzer, et
al., 2010). It is comprised of 42 questions and is to be administered by a clinician to the client.
The PDUQ is utilized to assess the client’s pain condition, opioid use patterns, social and family
factors, family history of pain and substance abuse, and psychiatric history. According to the
guidelines, a score greater than 11 on the PDUQ is considered a positive indicator for the Drug
Misuse Index. The Addiction Behaviors Checklist (ABC) is a 20 item assessment tool that was
designed to identify key behaviors that are associated with addiction to prescription opioid
medications commonly seen in the chronic pain populations. The assessment is comprised of
“yes” and “no” statements and completed by a physician (i.e. the client ran out of prescription
medication before indicated by the dosage); therefore, the assessment is focused on objective
information. If a client scores a three or higher on the ABC the client is considered to be
displaying inappropriate prescription drug use. The Drug Misuse Index (DMI) is determined by a
positive score on the PDUQ, the ABC, and the urine toxicology results (Jamison, et al., 2010).
The results of this study showed 32% of the participants scored an eleven or higher on the
PDUQ; whereas, only 16% of the participants scored a three or higher on the ABC. Urine
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toxicology screenings showed that 19% of the participants had used marijuana or additional
opioids that were not prescribed. Overall, 39% of the participants were positive for the DMI
which was reflected by their PDUQ answers, ABC evaluation, and a positive urinalysis. Almost
75% of the high-risk experimental group scored a positive result on the DMI; whereas, a little
over 25% of the high-risk control group and the low-risk experimental group received a positive
score on the DMI (Jamison, et al., 2010).
The assessment tools utilized in this study helped to objectively and subjectively identify
chronic pain clients that were abusing their prescription medications. Participants also indicated
that they felt the study helped them to remain complaint with their pain regimen.
Although this study was conducted over a long period of time, the data may be useful to
help construct an assessment tool that can be implemented in an ED setting. As seen in this
study, many of the participants suffering from chronic pain and using prescription opioids were
at a higher risk for developing an addiction to prescription substances which supports the theory
that a large percentage of drug-seekers in the ED are more than likely suffering from chronic
pain and an addiction to prescription medication (Jamison, et al., 2010).
The limitations of this study included a small sample size, a high propensity for loss of
subjects due to the requirements to complete the study, and an abundance of data to be collected
and analyzed which may have lead to erroneous results. In order to make the evidence collected
in this study more pertinent to application in emergency medicine additional research needs to be
completed in an ED setting.
In a study conducted in Sacramento, California 113 clients visiting the ED and Urgent
Care Centers were recruited to participate in a study that used the following evaluations: the
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SOAPP, BPI, HADS, PDI, the Spielberg State-Trait Anxiety Inventory (STAI), and the
Personality Diagnostic Questionnaire (Wilsey, et al., 2008b). This study sought to identify
psychological cormobidities associated with drug-seeking in the ED. Of the 113 participants
interviewed, 81% showed positive signs for a propensity for prescription drug abuse, 59% of the
participants were within the range for clinical depression, 39% met the criteria for a state of
anxiety, 34% of the participants also met the requirements for post traumatic stress disorder
(PTSD), and over half of the participants were likely to have a personality disorder (Wilsey et
al., 2008b).
Drug Screening
Another tool to aid in identifying drug-seekers is drug screening. The quickest, most
effective, way to discover what drugs are in a clients system is by simply implementing a
urinalysis (Ives et al., 2006). Tests using blood, hair, saliva, or sweat are also available.
However, the most commonly exercised is a simple urinalysis (Schuckman, et al., 2008). Several
articles researched the validity of using drug screening as a tool for identifying substance
abusers.
Summa Health System researchers focused on self-report of drug use in comparison with
the results of a urinalysis in an effort to establish a base line of underreporting of substance abuse
in the ED. A retrospective study of 248 clients meeting the inclusion criteria and treated at a
university-affiliated hospital in the Ohio area was conducted over a 6-year period. Subjects
presented to the ED with a primary complaint of back pain, headache, or toothache. Even
though participants were aware of the drug screening, 33% of the 238 participants had positive
results for unclaimed drugs. Participants with a history of drug abuse, that requested a specific
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narcotic or with chronic pain were significantly more likely to test positive for unclaimed drugs.
Of the 238 participants, 10% tested positive for cocaine, and 4% for opioids (Schuckman, et al.,
2008).
Study results showed that self-report of substance abuse is unreliable and more objective
measures may be required in order to identify drug-seekers. Further research is necessary due to
the limitations associated with attempting to screen for drugs with a short half life that are
expelled from the system quickly or cannot be detected in the urine. The limitations of this study
also included an increased potential for non-compliance with drug screening due to the
implications of testing positive for an unclaimed drug. Research using anonymous specimens
may prove more beneficial (Schuckman, et al., 2008).
Findings in a prospective cohort study conducted in North Carolina focusing on clients in
a chronic pain management program showed similar results. Participants were periodically
screened over a 12 month period for medications not prescribed and/or concurrent illicit drug
use. The participants were required to undergo a preliminary health and physical exam which
included collecting biographical data, pain assessment, disability, temperament, level of
education, and ability to complete required material. Of the 196 participants, 32% were positive
for opioid misuse. Participants with chronic pain, a history of drug use, or previous legal
complications as a result of alcohol or drug use were considerably more likely to have positive
urinalysis (Ives, et al., 2006).
Both studies report that clients with chronic pain or a history of substance abuse are at a
higher risk for denying the use of illegal substances. Furthermore, they agree that drug
screenings have limitations due to the short half-lives of frequently abused substances. The
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researchers also agree that it is necessary to implement drug screening when substance abuse is
suspected because self report is an unreliable source of information (Schuckman, et al., 2008).
Limitations to this study include, as with other studies, excludes participants with a history of
psychiatric disorders limiting the available information on self report of clients with mental
illness (Ives, et al., 2006).
A cross-sectional probability sample survey was conducted in 81 hospitals throughout the
Tennessee area. The 1,502 participants meeting the inclusion criteria for the study were
interviewed and provided a specimen for analysis. The results showed some similarity and
significant differences to other studies in this review. Marijuana, benzodiazepines, and opioids
are the most prevalent underreported substances abused. Researchers also found a predominance
of substance abuse identified in 10% of females ages 65 and over which showed a propensity for
abusing opiates, benzodiazepines, and stimulants (Rockett, Putnam, Jia, & Smith, 2006).
The limitations of this study are similar to the previous two studies and include a variable
window for detecting certain substances, limitations on compliance with drug screening, and the
exclusion of participants with mental health problems. The results support the unreliability of
self reports indicating a need for drug screening in the ED. A large number of participants were
unwilling to provide a specimen to be analyzed. In this study it was also indicated that there is a
risk of false positive results (Rockett, et al., 2006).
Prescription Monitoring
Recently several states including Illinois, Minnesota, Ohio, Tennessee, and Virginia have
been working to develop a statewide prescription monitoring program. A prescription monitoring
program helps decrease hospital shopping, physician shopping, and filling prescriptions in
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multiple pharmacies. When drug-seekers are identified and forced to limit the number of
prescriptions they obtain it will hopefully lead to a decline in prescription drug abuse.
Ohio initiated a statewide prescription monitoring program in 2006, referred to as the
Ohio Automated Rx Reporting System (OARRS). This system monitors the prescription drugs in
schedules II, III, IV, and V, carisoprodol products, and tramadol products. Information is
collected from pharmacies and distributors bi-weekly and made readily available to physicians,
pharmacists, and law enforcement agencies. Information from more than 18 million prescriptions
is distributed on the internet via encrypted files. The study conducted by the University of
Toledo Medical Center ED used the information available through the OARRS to observe for
changes in client care (i.e., medication, dose, and diagnosis) and what specific information lead
to these decisions (Baehren, et al., 2009).
Participants were adults with a chief complaint of dental, neck, back, head, joint, or
abdominal pain not related to acute injury and/or trauma. Health care providers working in the
Toledo Medical Center ED where given the opportunity to assess clients and make an educated
clinical decision about the treatment they would provide. After the exam was completed a
research assistant would administer a survey to assess what treatment they would provide, then
given the information obtained through the OARRS system, after which they were given a
follow up survey about how the data provided by the OARRS system changed their treatment
method (Baehren, et al., 2009).
Data analysis showed that ED providers were likely to alter their treatment plan based on
the information provided by the OARRS system. In fact, opioid prescribing was altered for 41%
of clients. When prescribing decisions changed, 61% of physicians were for reduced or no opioid
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medication while 39% received a larger prescription. Common reasons for physicians altering
opioid prescription practices were related to the number of previous prescriptions filled, the
number of physicians writing prescriptions, the number of pharmacies filling prescriptions, and
the number of addresses listed for the client (Baehren, et al., 2009).
The information provided by this study showed that a prescription monitoring program
affects ED physician treatment plans. The OARRS provides information to health care providers
that otherwise would only be obtained through self report which has been show to be unreliable.
The most important study finding was not that physicians altered their treatment plan, but that in
many cases, physicians saw that a client they suspected of drug-seeking was more than likely in
pain (Baehren, et al., 2009). This study was limited to one facility and the information posted in
the OARRS is reported to be delayed by almost three weeks (Baehren, et al., 2009).
There are several limitations to implementing an effective prescription monitoring
program, with the most obvious flaw being the difficulty of interstate monitoring. Without this
feature, drug-seekers can simply circulate between states. In an effort to overcome this flaw,
states have been working together to develop cooperative prescriptive monitoring. This would
solve one problem but still leave the obstacle of overcoming regulations established by Health
Insurance Portability and Accountability Act (HIPPA) (Baehren, et al., 2009).
Summary
Overall, the findings showed evidence that drug-seeking can be identified in a variety of
settings, including the ED. Identifying common drug-seeking behavior through assessment of the
client by using proper evaluation tools is both possible and essential. In order to make educated
decisions about drug-seekers in the ED objective assessments include drug screening and
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prescription monitoring which have been proven to be effective tools for identifying substances
abusers. Through this integrative literature review, a variety of methods have been shown to be
effective for the use of identifying drug-seekers; however, they have not yet been well
researched for effectiveness in the ED.
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DISCUSSION
The purpose of this integrative review of literature was to identify common drug-seeking
behaviors in the ED, identify previous research on the topic, and evaluate measurement tools for
drug-seeking clients. Common drug-seeking behaviors include pain complaints that are difficult
to objectively validate, hospital shopping, requesting or having allergies to specific medications,
and having a psychological cormobidity. Several methods have been identified to adequately
recognize the signs and symptoms associated with substance abuse in order to provide the proper
care. The findings showed that assessment, drug screening, and prescription monitoring
programs can help identify drug-seekers by focusing on the common behaviors associated with
substance abuse.
Assessment
Eight of the research articles reviewed showed similar assessment tools can be utilized to
identify drug-seekers in the ED. The evaluation devices most commonly used in the research
included: the Addiction Behaviors Checklist (ABC), the Brief Pain Inventory (BPI), the Current
Opioid Misuse Measurement (COMM), the Hospital Anxiety and Depression Scale (HADS), the
Pain Disability Index (PDI), the Prescription Drug Use Questionnaire (PDUQ), and the Screener
for Opioid Abuse for Pain Patients (SOAPP). The assessment tools utilized in this research were
constructed specifically to identify drug abusers, and their use can be an effective way to
recognize common signs and symptoms associated with drug-seeking (Jamison, et al., 2010;
Meltzer, et al., 2010).
It must be noted that none of the assessment tools has been evaluated in the ED setting.
Time and other environmental constraints associated with the ED may change instrument
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performance. Modified or condensed versions of existing instruments may be required for the
ED setting (Meltzer, et al., 2010). Furthermore, many of the instruments seen in this review
were administered and interpreted by trained experts. In order for these assessment tools to be
successfully implemented in the ED, practitioner training in both administration and
interpretation may be required.
Drug Screening
Implementing drug screenings has been shown to be an effective tool for identifying drug
abusers. There are a variety of methods to administering a drug screening which require a
biological specimen, such as blood, hair, urine, saliva, or sweat. However, the most commonly
utilized method is a urinalysis. Of the articles reviewed, three focused on validity of use drug
screening as a tool for identifying substance abusers. The information obtained showed
conflicting results with self report and the results from a urinalysis, thus indicating that self
report is an unreliable source of substance abuse history (Ives, et al., 2006; Rockett, et al., 2006;
Schuckman, et al., 2008).
The research showed that the most unreliable reporters of substance abuse are clients
with chronic pain, a history of substance abuse, or a history of legal complications associated
with alcohol or drug use. The research suggested that tobacco users and clients with no history of
substance abuse are among the most reliable of self reported use. The implementation of drug
screening in the ED will help to identify substance abusers suspected of drug-seeking which will
help to conserve resources and decrease expenditures (Ives, et al., 2006). Unfortunately, drug
screening is only effective in identifying substances that remain in the body for a long period of
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time showing that drug screening should be used in conjunction with additional tools to identify
drug-seekers.
Other issues associated with implementing drug-screening in the ED are resource
utilization, costs, and client privacy. Specimens for a urinalysis must be collected and sent to the
hospital laboratory for analysis which increases both resource utilization and costs. There is also
debate regarding client privacy rights and drug screening, unless the screening is medically or
legally justifiable (Rockett, et al., 2006). Although an effective way to identify individuals who
have recently used certain types of drugs, widespread use of urine drug screening requires more
research and debate.
Prescription Monitoring
As prescription substance abuse becomes more prevalent, government officials are
attempting to address the problem by implement statewide prescription monitoring programs.
Ohio developed a statewide prescription monitoring program referred to as the Ohio Automated
Rx Recently Reporting System (OARRS). Shortly after the program was initiated researchers
attempted to support the validity of the program by discovering if prescription monitoring affects
the treatment provided by healthcare providers. The research reported that a successful
prescription monitoring program has a direct effect on the treatment that physicians provide
(Baehren, et al., 2009).
Although prescription monitoring has been shown to be an effective tool for helping
physicians to make more informed decisions about providing medications, care must be taken to
protect clients’ rights to privacy. Statewide monitoring programs are also ineffective at
monitoring clients crossing state lines to hospital shop. Prescription monitoring is also
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ineffective at identifying prescription drug abusers that obtain substances illegally (Baehren, et
al., 2009).
Summary
The research reviewed showed evidence regarding a variety of subjective and objective
methods to identify drug-seeking behaviors in the ED. Drug screening is a more concrete method
of discovering substance abuse but may be subjected to false positives or false negatives and
cannot screen for drugs with a short half-life (Schuckman, et al., 2008). Resources available to
help ascertain the true motive for a client can be identified through the use of prescription
monitoring programs which provide information about the number of prescription a client has
had, the physicians providing treatment, and the quantity of pharmacies that the client uses on a
regular basis (Baehren, et al., 2009). Incorporating these resources together to indentify drugseeking in the ED will make discovering substance abusers less complicated and more accurate.
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LIMITATIONS
Numerous limitations were noted in this integrative review of literature, including: small
sample sizes, limited resources, inadequate training, and a limited amount of research conducted
in EDs. In all but two of the studies reviewed sample size was limited to less than 250
participants. In the majority of the studies participants were recruited through convenience
sampling when studies utilizing randomized sampling show more statistically significant results.
The resources for these studies were also limited to utilizing one to four facilities in a close
proximity to each other. The majority of the research was completed outside of the ED.
An additional limitation seen with drug screening is a risk for skewed data from false
positive or false negative results. There is also a limitation in screening for commonly abused
drugs as they do not remain in a clients system for an extended period of time. Of the three
studies conducted by Ives and colleges in 2006, Rockett and colleges in 2006, and Schuckman
and colleges in 2008, there were also a high number of participants that refused to provide a
specimen for analysis even though they were instructed prior to beginning the study that they
would be required to while taking part in a drug screening (Ives, et al., 2006; Rockett, et al.,
2006; Schuckman, et al., 2008).
Limitations specific to prescription monitoring were also identified. Prescription
monitoring is necessary to screen for prescription drug abuse but is questionable to whether or
not HIPPA laws are being broken. It is important for client rights to be protected even if that
means that prescription monitoring cannot be continued. Limitations are also noted with
implementing statewide prescription monitoring programs because it does not provide a way to
monitor clients living on state lines where hospital shopping can cross state boarders.
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RECOMMENDATIONS FOR NURSING
Research
A variety of research has been conducted to facilitate a specific means of identifying
substance abusers. Unfortunately, most of the research completed is unique making comparing
results difficult. Additional research will need to be preformed based off of the research that has
been completed in order to identify trends, similarities, and accumulate additional evidence to
support the established theories about drug-seeking.
This integrative review of literature may promote further investigation into the topic
identifying drug-seeking behaviors in the ED. An area of immediate need is a valid and reliable
assessment tool that takes into consideration the uniqueness and limitations of the ED setting.
This may start with modifying instruments validated in primary care settings to function
effectively in the ED environment. Further research should examine additional signs and
symptoms that have not yet been recognized.
When performing future studies, it would be favorable for researchers to use a sample
size based on a power analysis to optimize the likelihood of detecting any differences if they
exist. Random sampling representative of the population will improve external validity and
generalizability of any results. Additional studies conducted incorporating more rigid standards
will help to produce more accurate and empirically valid evidence.
Education
Nurses must be educated regarding the impact that drug-seeking on the available
resources in the ED. Nurses should also receive education on proper management of clients
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suspected of drug-seeking, such as referral services, drug rehab centers, and available
alternatives to seeking care in the ED.
Practitioners should be educated about the available information from state wide
prescription monitoring programs and how to utilize the data when providing care. It is also
important for care providers to understand the limitations of drug screening and the implications
associated with administering a urinalysis, such as: cost, time constraints, and client rights.
Educating ED staff about the tools available to identify-drug seekers is an important aspect of
helping to provide effective pain management in the ED.
It is imperative that nurses also educate their clients about the risk factors associated with
substance abuse so that they can try to recognize what factors may make them more susceptible
to addiction. Clients suspected of drug-seeking should be educated about the variety of resources
available to help them recover from addiction. Nurses must also provide family education about
the risk factors for developing substance abuse and the signs and symptoms of substance abuse
so that they will be more capable of identifying drug-seeking behavior in their family member.
Practice
The results from this integrative review of literature have many implications for practice
in the emergency medical field. At present, no assessment tool has been validated and
successfully implemented in the ED. It is important for nurses to be aware of drug-seeking in the
ED and make the appropriate decisions in accordance with their facilities protocols while acting
as a client advocate.
When a practitioner’s assessment leads to concern that a client may be drug-seeking, a
thorough review of available medical history along with other available information (e.g., drug
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screen) is warranted. Signs and symptoms such as frequent ED visits for pain, a history of
substance abuse, or a record of allergies to specific non-narcotic pain medications may support
drug-seeing suspicions. Prescription monitoring as also been shown to be an effective tool to
guide treatment provided. Providers can utilize the information obtained by prescription
monitoring programs to provide effective pain management in the ED.
A nurse’s primary concern should always be centered on the comfort and well-being of
their client. The nurse is the client advocate and must work to ensure the client is receiving
proper care. That is why it is essential for a client to receive a comprehensive assessment
including physical, history, and drug screening when indicated. The research shows that there is
no single assessment tool to identify drug-seeking behaviors in the ED. However, practitioners
using valid assessment tools, drug screening, and prescription monitoring may be able to more
quickly and appropriately identify substances abusers presenting to the ED.
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